Section to complete information about primary and secondary outcomes including. It includes the metric or method of measurement used and, the time point for every outcome.
Primary outcome(s):
1. Palmar sudation, (was eliminated, improved, was unchanged or became worse): at the end of treatment, 6 months and 12 months after treatment
Key secondary outcomes:
1- Physical limitation: (appearance or not from compensatory sweating, thermal disregulation or Claude-Bernard-Horner syndrome as adverse events in mayor o minor degree (no, slight, moderate, severe). Measurement time: at the end of the treatment, immediately, 6 month and 12 months after treatment. 2- Psychological limitation (no, slight, moderate, severe) Measurement time: at the end of the treatment, immediately, 6 month and 12 months after treatment. 3- Complications: (Neumothorax, Hemothorax, Loco-regional sepsis and persistent pain). Measurement time: at the end of the treatment, immediately, 6 month and 12 months after treatment. 4- Cost/utility. Measurement time: 1 year after treatment. 5- Psychological test (SRDARE, Prueba de Zung y Conie). Measurement time: Previus and postreatment for each group.